A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

A Multicenter, Randomized, Double-blind Clinical Study to Examine the Efficacy and Safety of Zarzenda in Comparison to Elidel in the Management of Mild to Moderate Atopic Dermatitis in Children and Adolescents

To show therapeutic efficacy of Zarzenda cream compared to Elidel cream in children and adolescents with mild to moderate atopic dermatitis

Inclusion Criteria:

• male and female children and adolescents (aged 2 - 17)
• mild to moderate atopic dermatitis
• patients in whom a treatment with topical corticosteroids in not recommended or possible
• wash out periods to be observed

Exclusion Criteria:

• known allergy to one of the two treatments
• known immunodeficiency
• known hepatic or renal insufficiency
• acute skin infections